MARKET

RVPH

RVPH

Reviva Pharmaceutcls Hldgs Inc
NASDAQ
0.7581
+0.0125
+1.68%
Pre Market: 0.7698 +0.0117 +1.54% 05:33 04/23 EDT
OPEN
0.7440
PREV CLOSE
0.7456
HIGH
0.7787
LOW
0.7020
VOLUME
8
TURNOVER
--
52 WEEK HIGH
4.280
52 WEEK LOW
0.4850
MARKET CAP
35.43M
P/E (TTM)
-0.8399
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RVPH last week (0414-0418)?
Weekly Report · 1d ago
Weekly Report: what happened at RVPH last week (0407-0411)?
Weekly Report · 04/14 11:46
Reviva Pharmaceuticals: Promising Schizophrenia Treatment Drives Buy Rating
TipRanks · 04/09 12:35
REVIVA PHARMACEUTICALS HOLDINGS INC <RVPH.O>: BENCHMARK CUTS TARGET PRICE TO $14 FROM $17
Reuters · 04/09 11:29
Weekly Report: what happened at RVPH last week (0331-0404)?
Weekly Report · 04/07 11:45
Biotech Alert: Searches spiking for these stocks today
TipRanks · 04/04 15:50
Roth MKM Reaffirms Their Buy Rating on Reviva Pharmaceuticals Holdings (RVPH)
TipRanks · 04/04 12:56
Reviva Pharmaceuticals Reports 2024 Financial Results
TipRanks · 04/02 03:58
More
About RVPH
More
Reviva Pharmaceuticals Holdings, Inc. is a late-stage pharmaceutical company. The Company discovers, develops, and seeks to commercialize therapeutics for diseases representing unmet medical needs. The Company’s pipeline focuses on the central nervous system, inflammatory, and cardiometabolic diseases. Its pipeline includes two drug candidates, brilaroxazine (RP5063) and RP1208. Its lead drug candidate, brilaroxazine, is in clinical development and is to treat multiple neuropsychiatric indications. These include schizophrenia, bipolar disorder (BD), major depressive disorder (MDD), attention-deficit/hyperactivity disorder (ADHD), behavioral and psychotic symptoms of dementia or Alzheimer’s disease (BPSD), and Parkinson’s disease psychosis. Brilaroxazine is also ready for clinical development for two respiratory indications, including pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF). Its RP1208 drug candidate is a triple reuptake inhibitor (TRI).
Recently
Symbol
Price
%Change

Webull offers Reviva Pharmaceuticals Holdings Inc stock information, including NASDAQ: RVPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVPH stock methods without spending real money on the virtual paper trading platform.